Latest news
Scientists uncover how pathogens switch on their virulence
A research team has uncovered how a key protein switches on the machinery that enables Leptospira pathogens to survive and cause disease. The findings provide new insights into how pathogens regulate their virulence and may open new avenues for therapeutic interventions.
New study suggests reduced newborn hepatitis B vaccination coverage may increase infant infections
Researchers found that lower vaccination coverage among infants born to unscreened mothers was associated with a substantial increase in HBV infections.
Where people get their news influences their beliefs about vaccines
People who follow “new right” media outlets are more than twice as likely to be vaccine-hesitant compared to those who never engage with those outlets, a new study finds. Hesitant adults were more likely to rely on non-authoritative sources for health information.
Global Virus Network statement on H5N1 vaccine developments
The new vaccine momentum reflects the growing urgency of avian influenza (H5N1) threat and reinforces the need for coordinated global preparedness.
Researchers discover new mosquito-specific viruses
A new study looked at mosquitoes’ immune response to discover many more insect viruses. Researchers hope to someday use the mosquitoes’ own immune system to battle some of the most pervasive and antagonistic human viruses.
New cellular target prevents hepatitis E infection
To replicate, a virus must first enter a host cell. In a recent study, the researchers specifically investigated host cell processes required for successful HEV infection. In doing so, they identified the enzyme PIKfyve as a crucial factor for viral entry.
Scientists uncover how pathogens switch on their virulence
A research team has uncovered how a key protein switches on the machinery that enables Leptospira pathogens to survive and cause disease. The findings provide new insights into how pathogens regulate their virulence and may open new avenues for therapeutic interventions.
New study suggests reduced newborn hepatitis B vaccination coverage may increase infant infections
Researchers found that lower vaccination coverage among infants born to unscreened mothers was associated with a substantial increase in HBV infections.
Where people get their news influences their beliefs about vaccines
People who follow “new right” media outlets are more than twice as likely to be vaccine-hesitant compared to those who never engage with those outlets, a new study finds. Hesitant adults were more likely to rely on non-authoritative sources for health information.
CDI breakthroughs lead to new drug development deal for deadly NTM bacteria
Scientists have developed new compounds against non-tuberculous mycobacteria which are now the subject of a new collaboration and license agreement with the Switzerland-based and publicly listed BioVersys AG.
Vanderbilt Center for Antibody Therapeutics signs agreement to develop anti-measles antibody treatment
The Vanderbilt Center for Antibody Therapeutics has signed an option agreement with Saravir Biopharma Inc. for the company to develop human monoclonal antibodies isolated in the laboratory of James Crowe Jr., MD, for the treatment and prevention of measles.
Cleanroom specialist Total Clean Air appointed European partner for US-based biodecontamination firm, TOMI
UK-BASED cleanroom engineering company Total Clean Air (TCA), a UKAS ISO 17025-accredited cleanroom constructor, has been appointed European partner for US-based decontamination technology firm TOMI®Environmental Solutions.
A universal toolkit for editing bacterial DNA
A major collaboration involving nine labs has transferred a particularly useful DNA editing system from E. coli into 14 new species of bacteria, spanning three major branches of the bacterial family tree.
Computational approach takes the guesswork out of drug development for Chagas disease
Researchers have established a computational protocol that could accelerate the development of more effective treatments for life-threatening parasitic infections such as Chagas disease, by enabling scientists to accurately identify reactions that can result in successful drug candidates without the need for trial and error.
Researchers fight oral cancer with bioengineered chewing gum
Research shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.
Global Virus Network statement on H5N1 vaccine developments
The new vaccine momentum reflects the growing urgency of avian influenza (H5N1) threat and reinforces the need for coordinated global preparedness.
Phage therapy at a turning point: Valencia 2026 to define the next era of antibacterial medicine
The Targeting Phage Therapy 2026 Congress will bring together leading scientists, clinicians, microbiologists, engineers, biotech leaders, regulators, hospital teams, start-ups, and innovators to ask: How can phage therapy move from promising science to accessible, validated, and deployable medicine?
How scientists are breeding spinach to better withstand Pythium
Breeding efforts to improve spinach tolerance to a pathogen called Pythium will help both indoor and outdoor growers of the popular leafy green.